Page 5,400«..1020..5,3995,4005,4015,402..5,4105,420..»

Breakthrough Stroke Treatment Pioneered by Edward Tobinick M.D. and Taught at Neurological Wellness Center Results in …

Posted: Published on April 24th, 2013

Newly released article details "New Hope for Survivors of Stroke and Traumatic Brain Injury". (PRWEB) April 24, 2013 "Rarely do we see such a radical breakthrough in medical treatment as this for stroke." "These results represent a sea change in the therapeutic possibilities for stroke and TBI patients. Our team observed first hand, rapid clinical improvement in stroke patients following this brief office treatment," said Professor Ralph. "Dr. Ralph visited Neurological Wellness Center in Managua, Nicaragua in 2012 where he learned to preform perispinal injections," said Dr. Augusto Ramirez M.D. of Neurological Wellness Center. Neurological Wellness Center physicians began teaching perispinal injection technique for the drug Enbrel in 2010. Since then physicians, nurses and caregivers from every continent have visited the center. "We have amassed a trove of anecdotal reports confirming the efficacy of perispinally injected Enbrel for the treatment of stroke, TBI and Alzheimer's disease," said Dr. Ramirez. For injections of Enbrel to be effective they must be administered to the soft fatty tissue in the back of the neck between cervical vertebrae C-5 and C-6. This simple subcutaneous injection, performed with a fine gauge inch needle, is referred to as a perispinal injection. Neurological Wellness Center offers a … Continue reading

Posted in Brain Injury Treatment | Comments Off on Breakthrough Stroke Treatment Pioneered by Edward Tobinick M.D. and Taught at Neurological Wellness Center Results in …

After brain injury, new astrocytes play unexpected role in healing

Posted: Published on April 24th, 2013

Apr. 24, 2013 The production of a certain kind of brain cell that had been considered an impediment to healing may actually be needed to staunch bleeding and promote repair after a stroke or head trauma, researchers at Duke Medicine report. These cells, known as astrocytes, can be produced from stem cells in the brain after injury. They migrate to the site of damage where they are much more effective in promoting recovery than previously thought. This insight from studies in mice, reported online April 24, 2013, in the journal Nature, may help researchers develop treatments that foster brain repair. "The injury recovery process is complex," said senior author Chay T. Kuo, M.D., PhD, George W. Brumley Assistant Professor of Cell Biology, Pediatrics and Neurobiology at Duke University. "There is a lot of interest in how new neurons can stimulate functional recovery, but if you make neurons without stopping the bleeding, the neurons don't even get a chance. The brain somehow knows this, so we believe that's why it produces these unique astrocytes in response to injury." Each year, more than 1.7 million people in the United States suffer a traumatic brain injury, according to the Centers for Disease Control … Continue reading

Posted in Brain Injury Treatment | Comments Off on After brain injury, new astrocytes play unexpected role in healing

Mild blast injury causes molecular changes in brain akin to Alzheimer

Posted: Published on April 24th, 2013

Apr. 24, 2013 A multicenter study led by scientists at the University of Pittsburgh School of Medicine shows that mild traumatic brain injury after blast exposure produces inflammation, oxidative stress and gene activation patterns akin to disorders of memory processing such as Alzheimer's disease. Their findings were recently reported in the online version of the Journal of Neurotrauma. Blast-induced traumatic brain injury (TBI) has become an important issue in combat casualty care, said senior investigator Patrick Kochanek, M.D., professor and vice chair of critical care medicine and director of the Safar Center for Resuscitation Research at Pitt. In many cases of mild TBI, MRI scans and other conventional imaging technology do not show overt damage to the brain. "Our research reveals that despite the lack of a lot of obvious neuronal death, there is a lot of molecular madness going on in the brain after a blast exposure," Dr. Kochanek said. "Even subtle injuries resulted in significant alterations of brain chemistry." The research team developed a rat model to examine whether mild blast exposure in a device called a shock tube caused any changes in the brain even if there was no indication of direct cell death, such as bleeding. … Continue reading

Posted in Brain Injury Treatment | Comments Off on Mild blast injury causes molecular changes in brain akin to Alzheimer

Company hope to test brain injury treatment

Posted: Published on April 24th, 2013

NEW YORK, N.Y. - A potential treatment for traumatic brain injuries may be tested in retired professional football players, who are the focus of concern over blows to the head. Neuralstem, Inc., of Rockville, Md., said Wednesday it is working with the National Football League Alumni Association to study the feasibility of such a test, which would need government approval. It would involve a drug that's now in an early human trial for treating depression. In animal studies, the drug appeared to stimulate creation of brain cells. Concern has mounted about brain injuries and disease in former NFL players, driven in part by some high-profile suicides. Thousands of former players are suing the league and its teams, saying that for years the NFL did not do enough to protect players from concussions. Copyright (c) Read the original here: Company hope to test brain injury treatment … Continue reading

Posted in Brain Injury Treatment | Comments Off on Company hope to test brain injury treatment

NFL may test brain injury treatment on retired players

Posted: Published on April 24th, 2013

NEW YORK The National Football League Alumni Association is working with Neuralstem, Inc., of Rockville, Md., to possibly test a potential treatment for traumatic brain injuries. 17 Photos If the plan goes through, the treatment would be tried on retired professional football players, who are the focus of concern over blows to the head. Neuralstem, Inc said Wednesday it is working with the National Football League Alumni Association to study the feasibility of such a test, which would need government approval. It would involve a drug that's now in an early human trial for treating depression. In animal studies, the drug appeared to stimulate creation of brain cells. Concern has mounted about brain injuries and disease in former NFL players, driven in part by some high-profile suicides. Thousands of former players are suing the league and its teams, saying that for years the NFL did not do enough to protect players from concussions. A lawyer representing the about 4,200 players told the Associated Press that the league held evidence about the damage concussions could do even after they created a Mild Trauma Brain Injury committee in 1994. Play Video Play Video "It set up a sham committee designed to get … Continue reading

Posted in Brain Injury Treatment | Comments Off on NFL may test brain injury treatment on retired players

Dr Zamboni Ms Treatment by NoMoreVitamins com – Video

Posted: Published on April 24th, 2013

Dr Zamboni Ms Treatment by NoMoreVitamins com http://NoMoreVitamins.com - Don't let yourself take pain pills for the rest of your life, please! There's another way no one has told you about, the holistic... By: steve matthews … Continue reading

Posted in MS Treatment | Comments Off on Dr Zamboni Ms Treatment by NoMoreVitamins com – Video

Fatigue Ms Treatment by NoMoreVitamins com – Video

Posted: Published on April 24th, 2013

Fatigue Ms Treatment by NoMoreVitamins com http://NoMoreVitamins.com - Don't let yourself take drugs for the rest of your life, please! There's another way no one has told you about, the holistic way,... By: theHealthFood Guru … Continue reading

Posted in MS Treatment | Comments Off on Fatigue Ms Treatment by NoMoreVitamins com – Video

Medivation Elects Dawn Graham to Board of Directors

Posted: Published on April 24th, 2013

SAN FRANCISCO, CA--(Marketwired - Apr 23, 2013) - Medivation, Inc. (NASDAQ: MDVN) today announced that Dawn Graham has been elected to the Company's Board of Directors.Ms. Graham joins Medivation following a 23-year career in pharmaceutical commercial leadership positions at Merck & Co. Inc., from which she retired in 2011 as President of Europe and Canada. "Dawn's depth of knowledge and experience in the pharmaceutical industry and her significant commercial expertise will make her an outstanding contributor to our board as we look to maximize the commercial opportunity for XTANDI and to diversify our portfolio to include other product candidates," said David Hung, M.D., president and chief executive officer of Medivation, Inc."The international commercialization expertise that Dawn brings to our board will be of particular benefit to Medivation as our business interests expand outside the United States." "With the recent launch of XTANDI, Medivation has established a strong foundation for global commercial success," said Ms. Graham."The speed and efficiency with which XTANDI was advanced from the laboratory to commercialization is quite impressive, and I look forward to working with the Medivation team to optimize XTANDI's commercial opportunity and to seek to replicate its successful track record with other potential product candidates." … Continue reading

Posted in MS Treatment | Comments Off on Medivation Elects Dawn Graham to Board of Directors

Local teen diagnosed with MS

Posted: Published on April 24th, 2013

Every day in the United States, a person is diagnosed with MS. But not every day does a 16-year-old receive that diagnosis. Cody Bryan of Menomonie, a sophomore at Menomonie High School, learned last summer that he has multiple sclerosis, a disease that affects the central nervous system, made up of the brain, spinal cord and optic nerves. Diagnosed at Rochester Hospital in Minnesota, Cody endured a week of treatments to help him regain feeling in his left arm and to stop the growth of lesions on his brain and spinal cord. He underwent a spinal tap, an MRI, X-Rays of his chest and numerous blood tests. Now he gives himself injections three times a week. But Cody is persevering and remains a typical teenage boy. His family says he loves listening to Bill Joel records and looks forward to getting his drivers license. Symptoms of MS can be unpredictable, making the disease even more of a challenge with which to live. Because nerves are affected, MS interupts the flow of information between the brain and the body, and movement can be difficult or cease altogether. Symptoms range from the mild numbness and tingling in the limbs to the severe, … Continue reading

Posted in MS Treatment | Comments Off on Local teen diagnosed with MS

Pipeline Progresses at ViroPharma – Analyst Blog

Posted: Published on April 24th, 2013

ViroPharma Incorporated ( VPHM ) recently announced results from a phase II study of its candidate VP20621 (non-toxigenic Clostridium difficile), which is being developed to prevent recurrent C. difficile infections (CDI), a gastrointestinal infection. The study (n=168) was conducted over 14 days wherein VP20621 was administered orally in adults previously treated for C. difficile- associated diarrhea (CDAD) with oral vancomycin or metronidazole. The patients were given either placebo or VP20621 after they completed their antibiotic treatment to evaluate the tolerability of the latter. Results from the study revealed statistically significant reductions in CDI recurrence in patients treated with VP20621 compared to those in the placebo arm. We note that at its inv day in Sep 2012, the company had designated VP20621 as a non-core asset. However, encouraged by the data, ViroPharma plans to seek a partner for the further development and subsequent commercialization of the candidate. We note that ViroPharma already has an approved drug, Vancocin indicated for the treatment of CDAD. Hence, ViroPharma plans to complete the evaluation of the phase II data to determine the pathway for future development. Nevertheless, ViroPharma also has maribavir in its pipeline, which is being developed for the treatment of cytomegalovirus (CMV) infections … Continue reading

Comments Off on Pipeline Progresses at ViroPharma – Analyst Blog

Page 5,400«..1020..5,3995,4005,4015,402..5,4105,420..»